InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Humacyte, Inc.

HUMA Clue Score41
United States Fiscal year ends December CIK 0001818382
$0.41 -9.35% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.41 −96.11% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 26 Aug 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Operating income−64.6Net income−66.5EPS, diluted−11.54Fiscal year 2021Operating income−81.2Net income−26.5EPS, diluted−0.66Fiscal year 2022Operating income−84.6Net income−12.0EPS, diluted−0.12Fiscal year 2023Operating income−100.0Net income−110.8EPS, diluted−1.07Fiscal year 2024Revenue0.0Operating income−114.4Net income−148.7EPS, diluted−1.26Fiscal year 2025Revenue2.0Operating income−108.1Net income−40.8EPS, diluted−0.26
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a 0.0 2.0
Growth
Operating income −64.6 −81.2 −84.6 −100.0 −114.4 −108.1
Net income −66.5 −26.5 −12.0 −110.8 −148.7 −40.8
Growth
EPS, diluted −11.54 −0.66 −0.12 −1.07 −1.26 −0.26

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−5,306.0%Net margin−2,003.6%Free cash flow margin−5,197.5%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a −5,306.0%
Net margin n/a n/a n/a n/a n/a −2,003.6%
Free cash flow margin n/a n/a n/a n/a n/a −5,197.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−55.6Capital expenditure−0.3Free cash flow−55.9Fiscal year 2021Operating cash flow−81.2Capital expenditure−0.2Free cash flow−81.4Fiscal year 2022Operating cash flow−71.1Capital expenditure−1.0Free cash flow−72.2Fiscal year 2023Operating cash flow−73.3Capital expenditure−2.3Free cash flow−75.6Fiscal year 2024Operating cash flow−98.1Capital expenditure−1.6Free cash flow−99.7Fiscal year 2025Operating cash flow−105.0Capital expenditure−0.9Free cash flow−105.9
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −55.6 −81.2 −71.1 −73.3 −98.1 −105.0
Capital expenditure −0.3 −0.2 −1.0 −2.3 −1.6 −0.9
Free cash flow −55.9 −81.4 −72.2 −75.6 −99.7 −105.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash39.9Shareholders’ equity−350.3Fiscal year 2021Cash217.5Total debt30.0Net cash (debt)187.5Shareholders’ equity122.2Debt to equity0.25Fiscal year 2022Cash149.8Shareholders’ equity116.9Fiscal year 2023Cash80.4Shareholders’ equity13.5Fiscal year 2024Cash44.9Total debt0.0Net cash (debt)44.9Shareholders’ equity−52.7Fiscal year 2025Cash50.5Total debt35.4Net cash (debt)15.1Shareholders’ equity3.1Debt to equity11.40
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 39.9 217.5 149.8 80.4 44.9 50.5
Total debt n/a 30.0 n/a n/a 0.0 35.4
Net cash (debt) n/a 187.5 n/a n/a 44.9 15.1
Shareholders’ equity −350.3 122.2 116.9 13.5 −52.7 3.1
Debt to equity n/a 0.25 n/a n/a n/a 11.40

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a n/a n/a 0.0 2.0
Growth
n/a n/a n/a n/a 0.0 9.7
54.1 61.3 63.3 76.6 88.6 69.3
12.0 21.1 22.9 23.5 25.8 31.2
−64.6 −81.2 −84.6 −100.0 −114.4 −108.1
Growth
n/a n/a n/a n/a n/a −40.8
0.0 0.0 0.0 0.0 0.0 0.0
−66.5 −26.5 −12.0 −110.8 −148.7 −40.8
Growth
Per share
−11.54 −0.66 −0.12 −1.07 −1.26 −0.26
−11.54 −0.66 −0.12 −1.07 −1.26 −0.26
Growth
5.8 40.0 103.1 103.4 118.5 158.2
5.8 40.0 103.1 103.4 118.5 158.2
Growth +593.2% +157.8% +0.4% +14.6% +33.5%

† The diluted share count jumps at 2021 and 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 6 of 6 years on file.